Stoke Mandeville Hospital is a large National Health Service hospital located on the parish borders of Aylesbury and Stoke Mandeville, Buckinghamshire, England. It is managed by Buckinghamshire Healthcare NHS Trust.

There are 369 beds in Stoke Mandeville Hospital.

During the past decade, Stoke Mandeville Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stoke Mandeville Hospital" #1 sponsor was "University of Oxford" with 5 trials, followed by "Lymphoma Trials Office" with 4 trials sponsored, "University College, London" with 3 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Institute of Cancer Research, United Kingdom" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stoke Mandeville Hospital" #1 collaborator was "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "Oxford University Hospitals NHS Trust" with 3 trials as a collaborator, "Lymphoma Trials Office" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Stoke Mandeville Hospital" are "Lymphoma" (7 trials), "Prostate Cancer" (3 trials), "Breast Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Stoke Mandeville Hospital" in a lesser frequency.

Most popular intervention types in "Stoke Mandeville Hospital" are "Drug" (20 trials), "Procedure" (7 trials), "Other" (6 trials), "Biological" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "chlorambucil" (4 trials), "doxorubicin hydrochloride" (4 trials), "vincristine sulfate" (4 trials) and "CHOP regimen" (3 trials). Other intervention names were less common.

The vast majority of trials in "Stoke Mandeville Hospital" are 25 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Stoke Mandeville Hospital". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Stoke Mandeville Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Stoke Mandeville Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".